Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presenter: Mahesh V. Madhavan

June 10, 2022

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

Presentation TVT 2022

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Presenter: Alexandra Lansky

June 10, 2022

Presentation TVT 2022

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

Presenter: Rebecca T. Hahn

June 10, 2022

Presentation TVT 2022

TV Repair Will Dominate: Safety Will Always Prevail!

Presenter: Paul Sorajja

June 10, 2022

Presentation TVT 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

Presenter: Rebecca T. Hahn

June 10, 2022

Presentation TVT 2022

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

Presenter: Mackram F. Eleid

June 10, 2022

Presentation TVT 2022

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Presenter: Susheel K. Kodali

June 10, 2022

Presentation TVT 2022

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

Presenter: Steven F. Bolling

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

ViMAC: Clinical Trial Update of TMVR Systems

Presenter: Mayra Guerrero

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Advertisement

Minorities, Poorer Patients Missing Out on Structural Heart Care

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

TV Repair Will Dominate: Safety Will Always Prevail!

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

More Support for Single Antiplatelet Therapy After TAVI

ViMAC: Clinical Trial Update of TMVR Systems

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content